Company intelligence / Profile preview
VaxForm
Pennsylvania, United Statesvaxform.com ↗
- Ownership
- Private
- Development stage
- Phase 1
01
Overview
VaxForm is developing several preclinical vaccine candidates including an oral COVID-19 vaccine, Streptococcus pyogenes vaccine, and an oral DTaP vaccine. Their latest research on COVID-19 vaccine formulation was published in September 2024.
- Therapeutic areas
- Infectious Diseases
- Modalities
- VaccinesOral vaccine deliveryAdjuvants
- Industry
- Biotech
02
Drug pipeline
4 assets3 more assets in the full pipeline.
Beyond the preview
Go deeper on VaxForm.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on VaxForm.